GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: ZLTQ
Buy $39

Zeltiq Aesthetics Inc (NASDAQ: ZLTQ) reiterated to Buy with price target $39 by Canaccord Genuity

Wednesday,  Mar 4, 2015  9:25 AM ET by Kristen Bailey

Canaccord Genuity reiterated Zeltiq Aesthetics Inc (NASDAQ: ZLTQ) to Buy with price
target $39. Canaccord Genuity rated Zeltiq Aesthetics Inc (NASDAQ: ZLTQ) to Buy with price target $28 on 09/19/2014, when the price was $25.04.

ZELTIQ Aesthetics, Inc. (ZELTIQ) is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product is the CoolSculpting System that reduces stubborn fat bulges. The Company generates revenues from capital sales of its CoolSculpting System and from procedure fees its physician customers pay for each CoolSculpting procedure they perform. As of March 31, 2011, it had an installed base of 346 and 475 CoolSculpting Systems worldwide and over 88,000 CoolSculpting procedures had been sold to its physician customers. The Company markets CoolSculpting to the dermatologists, plastic surgeons, and aesthetic specialists. As of March 31, 2011, ZELTIQ?s North American direct sales force consisted of 23 professionals, and over 88,000 CoolSculpting procedures were sold to ZELTIQ?s physician customers.

Canaccord Genuity’s global team of over 100 research professionals are inquisitive, experienced and committed to generating actionable investment ideas. We analyze over 725 companies in a broad range of market sectors, identifying value and defining risk for our clients.



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy